ZIMMER BIOMET HOLDINGS, INC.
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | Argus Research | reiterate | Buy → Buy | — | 54% |
| Oct 7, 2026 | Barclays | initiate | — → Equal-Weight | — | 53% |
| Aug 10, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Aug 7, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| Aug 6, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 9, 2026 | BMO Capital | initiate | Outperform → Market Perform | — | 53% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 28, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 29, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Apr 29, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 29, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Apr 29, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 29, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Apr 29, 2026 | Truist Securities | reiterate | Hold → Hold | — | 54% |
| Apr 29, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Apr 13, 2026 | Leerink Partners | initiate | — → Market Perform | — | 51% |
| Mar 23, 2026 | BTIG | downgrade | Buy → Neutral | — | 52% |
| Feb 12, 2026 | Barclays | maintain | Underweight → Underweight | $100 | 53% |
| Feb 11, 2026 | Citigroup | maintain | Neutral → Neutral | $98 | 54% |
| Feb 11, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $98 | 54% |
| Feb 10, 2026 | BTIG | reiterate | Buy → Buy | $112 | 52% |
| Feb 10, 2026 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jan 28, 2026 | UBS | maintain | Sell → Sell | $86 | 54% |
| Jan 9, 2026 | Bernstein | maintain | Market Perform → Market Perform | $99 | 52% |
| Jan 8, 2026 | BTIG | reiterate | Buy → Buy | $112 | 52% |
| Jan 5, 2026 | Evercore ISI Group | upgrade | In-Line → Outperform | $120 | 58% |
| Dec 16, 2025 | Baird | downgrade | Outperform → Neutral | $100 | 55% |
| Dec 11, 2025 | Citigroup | maintain | Neutral → Neutral | $94 | 54% |
| Nov 10, 2025 | Canaccord Genuity | maintain | Hold → Hold | $93 | 48% |
| Nov 6, 2025 | UBS | maintain | Sell → Sell | $88 | 54% |
| Nov 6, 2025 | RBC Capital | maintain | Outperform → Outperform | $101 | 55% |
| Nov 6, 2025 | Barclays | maintain | Underweight → Underweight | $104 | 53% |
| Nov 6, 2025 | JP Morgan | downgrade | Overweight → Neutral | $100 | 55% |
| Nov 5, 2025 | Barclays | maintain | Underweight → Underweight | $105 | 53% |
| Nov 5, 2025 | BTIG | maintain | Buy → Buy | $112 | 52% |
| Oct 22, 2025 | Canaccord Genuity | maintain | Hold → Hold | $101 | 48% |
| Oct 13, 2025 | BTIG | maintain | Buy → Buy | $122 | 52% |
| Oct 7, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $104 | 58% |
| Sep 19, 2025 | Stifel | maintain | Buy → Buy | $118 | 53% |
| Sep 18, 2025 | Rothschild & Co | initiate | — → Buy | $130 | 56% |
| Aug 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $115 | 55% |
| Aug 8, 2025 | UBS | maintain | Sell → Sell | $96 | 54% |
| Aug 8, 2025 | Raymond James | maintain | Outperform → Outperform | $113 | 54% |
| Jul 8, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $96 | 58% |
| May 12, 2025 | Canaccord Genuity | maintain | Hold → Hold | $101 | 48% |
| May 7, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $125 | 53% |
| May 6, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $104 | 54% |
| May 6, 2025 | Raymond James | maintain | Outperform → Outperform | $104 | 54% |
No cross-platform signals in the last 90 days